| Patient | James Madison |
|---|---|
| Date of birth | 2003-03-16 |
| Identifiers | MRN HR-EN007-SYN; SSN (made up) 000-07-2618 |
| Document date | 2026-04-07 |
| Author | Josiah Pembroke-Achebe, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
The patient attends this visit for primary care visit for two years of recurrent sudden episodes of unresponsiveness, with low mood and anxiety, on levetiracetam started without a diagnosis. [S]
PHQ-9: 13; GAD-7: 14; AUDIT-C: 1; Hemoglobin: 14.9 g/dL; White blood cells: 6.4 10*3/uL; Platelets: 231 10*3/uL; Sodium: 139 mmol/L; Potassium: 4.2 mmol/L; Creatinine: 0.86 mg/dL; eGFR: 125 mL/min/1.73 m²; Glucose: 84 mg/dL; Calcium: 9.6 mg/dL; TSH: 1.8 mIU/L; QTc: 404 ms. [S]
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-04-07 | Body height | 168 | cm | S |
| 2026-04-07 | Body weight | 54 | kg | S |
| 2026-04-07 | Body mass index (BMI) [Ratio] | 19.1 | kg/m2 | S |
| 2026-04-07 | Systolic blood pressure | 112 | mm[Hg] | S |
| 2026-04-07 | Diastolic blood pressure | 70 | mm[Hg] | S |
| 2026-04-07 | Heart rate | 76 | /min | S |
| 2026-04-07 | Respiratory rate | 14 | /min | S |
| 2026-04-07 | Body temperature | 36.7 | Cel | S |
| 2026-04-07 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-04-07 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 13 | {score} | S | ||
| 2026-04-07 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 14 | {score} | S | ||
| 2026-04-07 | Total score [AUDIT-C] | 1 | {score} | S | ||
| 2026-04-07 | Hemoglobin [Mass/volume] in Blood | 14.9 | g/dL | 13.2-16.6 g/dL | Normal | S |
| 2026-04-07 | Leukocytes [#/volume] in Blood by Automated count | 6.4 | 10*3/uL | 3.4-9.6 10*3/uL | Normal | S |
| 2026-04-07 | Platelets [#/volume] in Blood by Automated count | 231 | 10*3/uL | 150-400 10*3/uL | Normal | S |
| 2026-04-07 | Sodium [Moles/volume] in Serum or Plasma | 139 | mmol/L | 135-145 mmol/L | Normal | S |
| 2026-04-07 | Potassium [Moles/volume] in Serum or Plasma | 4.2 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 2026-04-07 | Creatinine [Mass/volume] in Serum or Plasma | 0.86 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 2026-04-07 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 125 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 2026-04-07 | Glucose [Mass/volume] in Serum or Plasma | 84 | mg/dL | 70-99 mg/dL | Normal | S |
| 2026-04-07 | Calcium [Mass/volume] in Serum or Plasma | 9.6 | mg/dL | 8.6-10.3 mg/dL | Normal | S |
| 2026-04-07 | Thyrotropin [Units/volume] in Serum or Plasma | 1.8 | m[IU]/L | 0.4-4 mIU/L | Normal | S |
| 2026-04-07 | Q-T interval corrected | 404 | ms | Below 450 ms is normal for a man | Normal | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Levetiracetam 500 mg oral tablet, one tablet twice daily, started at an emergency department visit four months before intake for possible seizures, without an EEG | One tablet twice daily | Oral route | 2025-12-02 to 2026-04-30 | completed | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Recurrent sudden episodes of unresponsiveness for two years, two or three a month: he 'blanks out', stops speaking, slumps or sinks to the floor with his eyes closed for two to ten minutes, and afterwards is tearful and tired, with no tongue biting, incontinence, or injury; first during a period of overwork and little sleep at college; with low mood and anxiety; unchanged on levetiracetam; under evaluation for epilepsy, functional (dissociative) seizures, syncope, and other causes | active | confirmed | R40.4 | S — Synthetic presenting problem echoing his documented overwork, infirm health, and low spirits, and the later accounts of sudden attacks; superseded by the diagnosis at the second visit. |
| Taking an antiseizure medicine (levetiracetam) started without a confirmed diagnosis of epilepsy | active | confirmed | Z79.899 | S — Synthetic medication problem for teaching about avoiding unneeded antiseizure medicines; resolved when the medicine was stopped. |